Humid Summers Promote Urban Aqueous‐Phase Production of Oxygenated Organic Aerosol in the Northeastern United States.

Authors: Rogers, Mitchell J., Joo, Taekyu, Hass‐Mitchell, Tori, Canagaratna, Manjula R., Campuzano‐Jost, Pedro, Sueper, Donna, Tran, Mia N., Machesky, Jo E., Roscioli, Joseph R., Jimenez, Jose L., Krechmer, Jordan E., Lambe, Andrew T., Nault, Benjamin A., Gentner, Drew R.

Source: Geophysical Research Letters; 2/28/2025, Vol. 52 Issue 4, p1-13, 13p

Nano-enabled, antimicrobial toothbrushes – How physical and chemical properties relate to antibacterial capabilities

Authors: Johnson, Clayton R. ^*, Tran, Mia Nhu, Michelitsch, Lisa-Marie, Abraham, Simi, Hu, Jinglin, Gray, Kimberly A., Hartmann, Erica M. ^*

Source: In Journal of Hazardous Materials 5 September 2020 396

Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis.

Authors: Girard, Nicolas, Besada, Mariam, Rogula, Basia, Lucherini, Stefano, Vo, Lien, Chaudhary, Mohammad A., Goring, Sarah, Lozano-Ortega, Greta, Tran, Mia, Varol, Nebibe, Waser, Nathalie, Lee, Jay M., Spicer, Jonathan

Source: Cancers; Jul2024, Vol. 16 Issue 13, p2492, 16p

Subject Terms: THERAPEUTIC use of antineoplastic agents, MEDICAL information storage & retrieval systems, RESEARCH funding, PATHOLOGIC complete response, TREATMENT effectiveness, CHEMORADIOTHERAPY, META-analysis, CANCER patients, DESCRIPTIVE statistics, CANCER chemotherapy, ADJUVANT chemotherapy, SYSTEMATIC reviews, ODDS ratio, MEDLINE, KAPLAN-Meier estimator, COMBINED modality therapy, MEDICAL databases, NIVOLUMAB, LUNG cancer, COMPARATIVE studies, PROGRESSION-free survival, TUMOR classification, PROPORTIONAL hazards models, EVALUATION

Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16 , 2492

Authors: Girard, Nicolas, Besada, Mariam, Rogula, Basia, Lucherini, Stefano, Vo, Lien, Chaudhary, Mohammad A., Goring, Sarah, Lozano-Ortega, Greta, Tran, Mia, Varol, Nebibe, Waser, Nathalie, Yu, Winifred W., Lee, Jay M., Spicer, Jonathan

Source: Cancers; Feb2025, Vol. 17 Issue 4, p674, 2p

Subject Terms: THERAPEUTIC use of antineoplastic agents, TREATMENT effectiveness, ADJUVANT chemotherapy, COMBINED modality therapy, NIVOLUMAB, LUNG cancer, EVALUATION

Association between pathologic response and survival after neoadjuvant therapy in lung cancer

Authors: Deutsch, Julie Stein, Cimino-Mathews, Ashley, Thompson, Elizabeth, Provencio, Mariano, Forde, Patrick M., Spicer, Jonathan, Girard, Nicolas, Wang, Daphne, Anders, Robert A., Gabrielson, Edward, Illei, Peter, Jedrych, Jaroslaw, Danilova, Ludmila, Sunshine, Joel, Kerr, Keith M., Tran, Mia, Bushong, Judith, Cai, Junliang, Devas, Vipul, Neely, Jaclyn, Balli, David, Cottrell, Tricia R., Baras, Alex S., Taube, Janis M.

Source: Nature Medicine; January 2024, Vol. 30 Issue: 1 p218-228, 11p